What role of autism in Fragile X?

This morning's session at the Keystone meeting on the pathophysiology of autism in Santa Fe, New Mexico, focused on the disorder's link to Fragile X syndrome. Like autism, Fragile X is associated with behaviors such as high social anxiety, gaze avoidance, and speech problems. A significant number of people with Fragile X - estimates range wildly from 5 to 60% - have autism, but a smaller number of linkurl:autistic cases are associated with Fragile X;http://www.the-scientist.com/article/d

Written byAlison McCook
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
This morning's session at the Keystone meeting on the pathophysiology of autism in Santa Fe, New Mexico, focused on the disorder's link to Fragile X syndrome. Like autism, Fragile X is associated with behaviors such as high social anxiety, gaze avoidance, and speech problems. A significant number of people with Fragile X - estimates range wildly from 5 to 60% - have autism, but a smaller number of linkurl:autistic cases are associated with Fragile X;http://www.the-scientist.com/article/display/15820/ (maybe on the order of 4% of or so). David Nelson from Baylor College of Medicine in Texas posed an interesting question: Why don't all Fragile X patients have autism? Are there stochastic, developmental, genetic modifiers? His group has tried to answer that question. Fragile X syndrome results from a mutation in the FMR1, or fragile X mental retardation gene, which encodes the FMRP protein. But in most patients, this mutation is mosaic, leading his group to hypothesize that changes in the Fmr1 mutation may explain this variety in phenotype. They found that FMR1-knockout mice (who also lacked a Fragile X related protein) had no circadian rhythm, even when exposed to light and dark. Nelson suggested that these findings show that the Fmr1 family helps control the body's internal clock, and changes to that family could underlie problems in learning and memory.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies